Now showing items 1-1 of 1

    • Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain. 

      Sisignano, M; Angioni, C; Park, C-K; Meyer Dos Santos, S; Jordan, H; Kuzikov, M; Liu, Di; ... (24 authors) (Proc Natl Acad Sci U S A, 2016-11-01)
      Chemotherapy-induced peripheral neuropathic pain (CIPNP) is a severe dose- and therapy-limiting side effect of widely used cytostatics that is particularly difficult to treat. Here, we report increased expression of the ...